Navigation Links
Lucas Group Reports Hiring Trend in High-Tech Medical Device
Date:9/12/2008

Lucas Group, an executive search firm, today reports a hiring trend over the past four months within High-Tech Medical Device, specifically Sales Directors. Companies and candidates are realizing it is has become a “recruiters” market causing both parties to change their ways of thinking.

(PRWEB) September 12, 2008 -- Lucas Group, an executive search firm, today reports a hiring trend over the past four months within http://www.lucasgroup.com/medical/index.asp [High-Tech Medical Device], specifically Sales Directors.

Companies and candidates are realizing it is has become a “recruiters” market causing both parties to change their ways of thinking. From the companies viewpoint – where they previously would hire a candidate who meet 80% of their requirements for a position are now looking for candidates who not only meet 100% of their requirements, but those who exceed. In other words, they will hire a qualified Vice President for a Director level position. Companies are hand-picking the candidates from larger pools allowing them to find their exact match and not settle. In turn, these candidates are making companies stronger and more efficient.

“There’s business, just not what we are accustomed to,” revealed Nancy Simon, Executive Senior Partner for Lucas Group, Medical Device.

To compete, candidates have to be more qualified, even a step above to be considered for positions. They can no longer state they have the experience and can easily learn a position; they have to prove they have done it statistically within the company’s specialties.

“The market is still viable,” said Nancy Simon. “You have to steer clear of the potholes but there are plenty of positions out there.”

To find the candidate
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. East Meets West at Cabo San Lucas New Saltwater Spa, Opening February
2. Orphan Therapeutics Announces Initiation of Rolling NDA Submission for LUCASSIN(R) (terlipressin) for the Treatment of Hepatorenal Syndrome Type 1
3. Lucas Group to Host Military Hiring Conferences in Washington, DC; Irvine, CA and Dallas, TX
4. Lucas Group Celebrates Its 38th Anniversary
5. Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
6. Broad-based group of physicians calls for improvement in stroke treatment
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
9. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
10. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
11. AMERIGROUP to Acquire Memphis Health Plan

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lucas Group Reports Hiring Trend in High-Tech Medical Device
Lucas Group Reports Hiring Trend in High-Tech Medical Device
(Date:12/4/2009)... While Congress debates ...re costs, Leapfrog,s purchaser members point to 45... the best quality care in the nation while attaini...rban, eight children,s and three rural hospitals h...on results from The Leapfrog Hospital Survey. ,...
(Date:12/4/2009)... study shows that muscle cells grown in the lab ca...roperly. The work, performed in dogs and rats, mig...such as gastric reflux and fecal incontinence. , ...rs, which are the bands of muscle that separate th...s in these areas can cause gastrointestinal esopha...
(Date:12/4/2009)...s are recruited annually to participate in clinica...rch Protection (AHRP), and most will be compensate...utions view payments to volunteers as compensation...tential risks related to participating in the expe...ve a very different view of clinical trial compens...
(Date:12/4/2009)...one immediately or 3 weeks later, study shows , ...g of surgical repair or reconstruction of multiple...come, a new study has found. , Multiple-ligamen...tions that can occur in high-impact car crashes or...rgery to repair these injuries hasn,t been definit...
(Date:12/4/2009)...wire/ -- Substantial progress has been made over t...lity to diagnose and treat epilepsy and its compli... has not reached most of the 50 million people aro...million people in the United States who have the d....D., president of the American Epilepsy Society (A...
Breaking Medicine News(10 mins):Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4
...ombination of a "targeted" therapy and chemotherap...rcent in one-fifth of patients with aggressive HER...ted by Dana-Farber Cancer Institute investigators ... which lapatinib given alone shrank brain metastas...
... studies from Mayo Clinics site in Jacksonville, F...brain, have found that women whose tumors do not h...rst overall outcomes. Because of this, these patie...t the San Antonio Breast Cancer Symposium. , Thos...
...mber 16, 2007 Psychosocial support in women with ...mportant as the need for disease- and treatment-re...y presented here today at the 30th Annual San Anto...also underscores the growing importance of the Int...
...erim results of the Phase II,XeNA (Xeloda in NeoAd...,Xeloda(R) (capecitabine) and Taxotere(R) (docetax...b) in HER2-positive patients, may be an active and...Breast Cancer Symposium (SABCS)., In the multi-ce...
... activate when scenting a stranger, study finds , ...e only ones who can sniff out interlopers. , Human...n previously believed and can use their nose to di... in a PET scanner, study volunteers were asked to ...
...tudy published in the December 15 issue of the Jou...s an association between short sleep times and obe... The study surveyed 200 patients attending interna... sleep times (less than seven hours) had a signifi...
Other Medicine News:Health News:Drug combination shrinks breast cancer metastases in brain 2Health News:Survival shortened when ER/PR negative breast cancer spreads to the brain 2Health News:Survival shortened when ER/PR negative breast cancer spreads to the brain 3Health News:Survey underscores importance of emotional/educational needs among women with advanced breast cancer 2Health News:Survey underscores importance of emotional/educational needs among women with advanced breast cancer 3Health News:Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle 2Health News:Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle 3Health News:Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle 4Health News:Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle 5Health News:Human Noses Sort Out Strangers, Friends 2Health News:Study: Short sleep times in patients with chronic medical diagnoses linked to obesity 2
(Date:12/4/2009)...Newswire/ -- Thermographic Diagnostic Imaging (TDI...on, New Jersey continues to provide superior quali...ystem, thyroid, dental, TMJ and sinus regions to a...d with these areas. ,, Thermography utilizes i...rared range of the electromagnetic spectrum and pr...
(Date:12/4/2009)...Deliveries are Transported ,, PHILADELPHIA, D...employed by the Philadelphia chapter of the Americ... about the unfair labor conditions that they endur...supply at risk. More than 100 employees went on s...r issues were ignored by their employer. ,, Red...
(Date:12/4/2009)... 4 Onyx Pharmaceuticals,...l host an investor teleconference and webcast. Pr...tations surrounding carfilzomib in relapsed and/or...1st American Society of Hematology (ASH) Annual Me... a.m. CT/10:00 a.m. ET on Monday, December 7, 2009...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Study 3A Lap band surgery effective for morbidly obese children 60640 1Expert predicts possible shift in senior voting bloc 60635 1Expert predicts possible shift in senior voting bloc 60635 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 10617 1UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 10617 2
... through the Provision of ...nnovative Fluorescent Imaging Agent and System ... Cancer, PHILADELPHIA, TOKYO and WOBURN, Mass, Ju...oday announced a partnership to advance,Phase I cl...uorescence,activatable imaging agents to enable ph...
...ciety of Hypertension demonstrate that early bloc... hypertrophy, PARSIPPANY, N.J....urnal of the American Society of Hypertension demo...n medoxomil was effective in reversing,the narrowi...pertension.,The study, titled VIOS (Vascular Impro...
Other Medicine Technology:Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies 2Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies 3Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies 4New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 2New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 3New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 4New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 5New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 6New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 7New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 8New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 9
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: